Recursion Pharmaceuticals $121 million Series C for AI drug discovery

Recursion Pharmceuticals has closed a $121 million Series C funding round, led by Scottish Mortgage Investment Trust, with participation from new and all prior institutional investors.

The funds will be invested to continue building Recursion's AI-enabled drug discovery platform, as well as to develop capabilities to accelerate new chemical entity chemistry and predict safety pharmacology.

Ablacon raises $21.5 million for atrial fibrillation AI
Ablacon, which is developing an atrial fibrillation (AFib) mapping system, has closed a $21.5 million Series A funding round led by Ajax Health.
Alex Guest Tue, 30/04/2019 - 16:47
908 Devices raise $17.5 million Series E led by Northpond Ventures
908 Devices, a pioneer of analytical devices for chemical and biomolecular analysis, has raised a $17.5 million Series E financing round led by Northpond Ventures.
Alex Guest Mon, 29/04/2019 - 15:00
Sonde Health raises $16 million Series A for vocal diagnostics
Sonde Health, which is developing a voice-based diagnostics platform, has secured $16 million in a Series A financing round led by M Ventures, with MP Healthcare Venture Management, Neoteny 4, LP, Canepa Healthcare, and founder PureTech Health
Alex Guest Thu, 11/04/2019 - 16:31

Signum Surgical wins €3.6 million grants for colorectal disease therapy

Signum Surgical, which is developing minimally invasive technologies to treat colorectal diseases, has secured two grants totalling €3.6 million:  €2.3 million from the EU Horizon 2020 SME Instrument, and €1.3 million from Ireland’s Disruptive Technologies Innovation Fund.